Cargando…

The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic Sulfatase-2 Gene in Breast Cancer Cells and Is Sensible Targets for Cancer Therapy

PURPOSE: Invasive breast carcinomas (BRCAs) are highly lethal. The molecular mechanisms underlying progression of invasive BRCAs are unclear, and effective therapies are highly desired. The cancer-testis antigen CT45A1 promotes overexpression of pro-metastatic sulfatase-2 (SULF2) and breast cancer m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ping, Qiao, Yingnan, Liao, Huaidong, Huang, Yizheng, Meng, Mei, Chen, Yu, Zhou, Quansheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139848/ https://www.ncbi.nlm.nih.gov/pubmed/37095619 http://dx.doi.org/10.4048/jbc.2023.26.e5

Ejemplares similares

Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
por: Yang, Ping, et al.
Publicado: (2022)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration
por: Koop, Anja, et al.
Publicado: (2013)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2015)

Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells
por: D’Arcy, Padraig, et al.
Publicado: (2014)

Sulfatase 1 and sulfatase 2 as novel regulators of macrophage antigen presentation and phagocytosis
por: Kim, Hyun-Je, et al.
Publicado: (2021)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
por: Suzuki, Izumi, et al.
Publicado: (2021)

Cancer/testis antigen 45 is expressed in a nuclear speckles-like pattern in human tumor cell lines
por: Heidebrecht, HJ, et al.
Publicado: (2009)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

Identification and Signature Sequences of Bacterial Δ(4,5)Hexuronate-2-O-Sulfatases
por: Wang, Shumin, et al.
Publicado: (2019)

Pattern of cancer/testis antigen expression in lung cancer patients
por: KIM, YEONG-DAE, et al.
Publicado: (2012)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Cancer/testis antigens (CTAs) expression in resected lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis
por: Shang, B, et al.
Publicado: (2014)

Sensible
Publicado: (1883)

The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer
por: Sinreih, Maša, et al.
Publicado: (2017)

Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma
por: Zhou, Jin-xue, et al.
Publicado: (2011)

Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013)

TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma
por: Yin, Y-H, et al.
Publicado: (2005)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2015)

Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
por: Khan, Ghazala, et al.
Publicado: (2015)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects()
por: Wei, Xiao, et al.
Publicado: (2019)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

The Role of Steroid Sulfatase as a Prognostic Factor in Patients with Endometrial Cancer
por: Lee, Won Moo, et al.
Publicado: (2016)

Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D
por: Zhu, Chenfang, et al.
Publicado: (2016)

Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells
por: Ye, Dong-Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i3nd8hjaelof94p7d0jar48nkl